Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 519 results for "biocon"

'Need to stop stereotyping women'

Author Gunjan Jain, Former MD Britannia Vinita Bali, Yasmeen Premji and Biocon CMD Kiran Mazumdar-Shaw at the book launch on Thursday | pushkar v BENGALURU: Prominent women personalities emphasised on the need to stop stereotyping what women can ... New Indian Express, 1 week ago

236 images for biocon

Deccan Chronicle, 4 days ago
Livemint.com, 3 weeks ago
Business Standard India, 3 weeks ago
India Infoline, 1 month ago
Financial Express, 4 weeks ago
The Hindu, 1 month ago
Money Today, 1 month ago
Samaylive, 1 month ago
Financial Express, 2 weeks ago
livemint.com, 1 month ago
The Hindu

EMA Accepts Mylan and Biocon's Application for Authorization to Market a Pegfilgrastim Biosimilar

Mylan N.V. and Biocon Ltd. recently that the European Medicines Agency has accepted Mylan's Marketing Authorization Application for a proposed biosimilar version of Amgen's Neulasta (pegfilgrastim). In Europe, Neulasta is indicated for the treatment ...
 JD Supra2 weeks ago Biocon Q1 Net Up 17% At Rs 147 Crore  Businessworld India3 weeks ago BIOCON : Mylan and Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency  4 Traders3 weeks ago EMA accepts to review Mylan and Biocon's regulatory submission for Pegfilgrastim  CPhI.cn1 month ago
[x]  
Business Standard India

Biocon: hope in the pipeline

The article below represents a preview only and is not meant for reuse or republishing. New Delhi, July 26 -- Biocon Ltd's shares have gained 65% since the start of this fiscal year. The stock declined a bit in early July but improved after its ...
 HT Syndication4 weeks ago Biocon: Positives factored in  Smart Investor1 month ago Biocon Hits Fresh 52-Week High On Strong Q1 Performance  NDTV1 month ago Biocon up over 5% post Q1 results, EMA review of Biosimilar  Smart Investor1 month ago
[x]  
Financial Express

Biocon: Positives factored in

The stock hit an all-time high and ended 15 per cent higher at Rs 808.70 on Friday
 Business Standard1 month ago Higher profit, robust drug pipeline help Biocon shares touch lifetime high  Times of India1 month ago Biocon hits new all-time high post Q1 results, shares surge over 15%  Financial Express1 month ago Biocon rallies 6% as drugmaker reports healthy growth in Q1 net  Economic Times1 month ago
[x]  
India Infoline

Syngene surges 1%; plans US$ 200 mn for capex

Biocon's research arm Syngene International is currently trading 1% higher at Rs.430 on BSE. The company has lined up US$ 200 million for capital expenditure. The company plans to invest $100 million (around Rs.665 crore) in a greenfield facility ...
 India Infoline1 month ago Syngene lines up $200 million capex to boost manufacturing  Pharmaceutical Tech.com1 month ago Syngene lines up $200 mn capex to boost manufacturing  Business Line1 month ago Syngene lines up USD 200 mn capex to boost manufacturing  Money Control1 month ago
[x]  
Med India

DCGI Grants Permission For New Eye Drug Trial

Biocon and its Israeli partner Quark Pharmaceuticals to proceed with human clinical trials for a new drug candidate, 'QPI-1007' targeting orphan eye disease. Advertisement Orphan eye disease is a condition that affects fewer than 200,000 people nationwide.
 Med India2 months ago Biocon, Quark get nod for trial of eye treatment  The Hindu2 months ago Biocon begins clinical trials for drug to treat rare eye disorder  Business Standard2 months ago Biocon, Quark get nod to start trials of eye disease drug  DNA2 months ago
[x]  
Financial Express

Biocon target price Rs 889; Morgan Stanley says base case scenario value

In this note, we present the two Q2 sales data points, as relevant to unfolding global bio-similar theme. These are related to Lilly's glargine in EU markets and Sandoz's overall biopharmaceutical portfolio. This is relevant to Biocon's upcoming ...
 Financial Express2 weeks ago Citi ups Biocon target price to Rs 935; raises EPS  Financial Express4 weeks ago

Cairn India, Biocon, Nestle India, Dalmia Bharat, Grasim hit 52-week high

 Smart Investor1 month ago 10 stocks that hogged limelight in Friday's trade: Bharat Financial, Biocon, Federal Bank and more  Financial Express1 month ago 'We have enhanced patient access to insulin across India'  Deccan Herald3 weeks ago

Biocon standalone net profit rises 38.90% in the June 2016 quarter

Sales rise 24.27% to Rs 645.60 crore
 Business Standard1 month ago Biocon consolidated net profit rises 34.46% in the June 2016 quarter  Business Standard1 month ago
India Infoline

ITC, Cairn India, Biocon, Zensar, Syngene in focus post Q1 nos

Some of the stocks that should be on your radar are: Sun TV Network, Dishman Pharmaceuticals Chemicals, ITC, Cairn India, Axis Bank, Biocon, Syngene International, Zensar Technologies, Thangamayil Jewellery.
 Money Control1 month ago Top 23 stocks in focus: ITC, Axis Bank, Biocon  India Infoline1 month ago Top 15 stocks in focus: Axis Bank, Cairn India, Biocon  India Infoline1 month ago Cairn India, HDFC Bank results in focus  India Infoline1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - biocon
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less